C14 is a financial technology company that provides a seamless fiat-to-crypto on-ramp solution for developers building on the Hedera blockchain network. Its core product is an easily embeddable widget that decentralized applications (dApps), wallets, and marketplaces can integrate directly into their platforms.
With C14's widget, users can purchase digital assets directly within the dApp they are using, employing familiar payment methods like credit or debit cards. The platform handles the entire transaction flow, including regulatory compliance aspects like Know Your Customer (KYC) checks, and delivers the purchased assets directly to the user's connected wallet. This creates a simple, "one-click" experience that significantly lowers the barrier to entry for mainstream adoption.
Project Information
Related Projects
ValueNature is a South Africa-based organization working to create a new class of nature-based commodity credits. The company's mission is to accelerate the recognition of nature's value by creating a transparent and efficient market for biodiversity and natural carbon credits.
ValueNature's core service is the facilitation of nature-based investment projects. They are actively developing projects across the Global South that are designed to generate both biodiversity and carbon credits. The company's methodology involves using a combination of on-the-ground sensor technologies and remote sensing data to measure and verify the positive impacts of these projects on local ecosystems. The goal is to create a robust and evidence-based system for quantifying and valuing nature, with a commitment to ensuring that 80% of the revenue from the sale of credits goes back to the local custodians of the land.
ValueNature is building its platform on the Hedera Guardian, an open-source toolset for creating and managing digital environmental assets. This allows for the tokenization of their biodiversity and carbon credits, creating a transparent and auditable record of their entire lifecycle.
MIOO Technology provides an enterprise-grade platform that connects physical products to the digital world through unique, verifiable digital identities. It specializes in creating Digital Product Passports (DPP), which enable users to track products through QR codes or NFC tags connected directly to a product or its label and secured on the immutable Hedera blockchain network giving them access to a wealth of information about the status of their goods.
The platform is designed to help brands, particularly in the luxury, fashion, and art sectors, combat counterfeiting and prepare for upcoming regulations like the EU’s Ecodesign for Sustainable Products Regulation (ESPR). The DPP can house detailed data on a product's materials, origin, carbon footprint, and repair history, promoting transparency and sustainability. For consumers, this digital identity serves as an undeniable certificate of authenticity and ownership. For brands, it opens a direct channel for post-sale customer engagement and provides valuable insights into the product lifecycle.
MIOO's technology is active in the micromobility sector with MIOO Cycling, an initiative supported by EIT Urban Mobility. This service uses the DPP to track a bicycle's entire lifecycle, including service history and ownership transfers.
Certara is a global leader in biosimulation, a technology that uses computer models to predict how drugs will behave in the human body. Founded in 2008 and headquartered in Princeton, New Jersey, its mission is to accelerate the development of new medicines by transforming the traditional drug discovery and development process.
The company offers a comprehensive suite of software and services that are used by over 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies in 62 countries. Certara's Simcyp Simulator, for example, is a physiologically-based pharmacokinetic (PBPK) modeling platform that is widely used to predict drug interactions. In addition to its software, Certara provides a range of consulting services, including regulatory science, market access, and medical writing.
Certara's OpenPharma innovation has developed a decentralized application called Hasharc that is built on the Hedera network and designed to address key challenges in the life sciences industry, such as supply chain security, patient safety, and regulatory compliance.
MetaStable is a decentralized finance (DeFi) platform that aims to provide a secure, private, and compliant environment for trading synthetic assets. The company is focused on leveraging advanced cryptographic techniques to solve some of the key challenges in the DeFi space, such as high slippage, impermanent loss, and regulatory uncertainty.
The core of MetaStable's service is its Automated Market Maker (AMM), which is designed to facilitate the trading of synthetic assets with minimal price impact. A key feature of the platform is its use of Zero-Knowledge Proofs (ZKPs), which allows for the verification of transactions without revealing the underlying data. This provides a high degree of privacy and confidentiality for users. The platform also includes a "DeFi Firewall," a proprietary technology that helps to ensure regulatory compliance by preventing illicit funds from entering the ecosystem.
MetaStable’s "chain-agnostic" design and support for EVM-compatible DLTs allows it be interoperable with various networks including the Hedera blockchain.